Aarhus Universitets segl

DCCC Dansk forskningscenter for cirkulerende tumor DNA guided kræftbehandling - støttet af Kræftens Bekæmpelse

Projekter: ProjektForskning

Se relationer på Aarhus Universitet


In January 2020 the National Danish ctDNA Research Center was established. The objective of the center is to provide an effective and vital framework for optimal implementation of evidence-based ctDNA usage in cancer patient management in Denmark.

With the center all Danish clinicians and researchers with an interest in using ctDNA based analysis for monitoring and decision making are brought together to facilitate ctDNA based research and clinical implementation of ctDNA guided patient stratification.

The center aims to offer participation in evidence generating clinical trials to all relevant Danish cancer patients. Such trials will explore the clinical utility of using ctDNA for e.g. detection of cancer in asymptomatic individuals, post-operative detection of residual disease to guide adjuvant treatment decisions, detection of residual disease after adjuvant therapy in order to guide imaging surveillance intensity, for blood-based recurrence surveillance, for monitoring therapy response (neoadjuvant, adjuvant and in treatment of metastatic disease), detection of actionable targets for guiding therapy choice etc.
Kort titelDCCC ctDNA Forskningscenter
Effektiv start/slut dato01/01/202031/12/2025


  • circulating tumor DNA, solid tumors, Denmark, Natitional, center, collaboration

ID: 208799338